Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Warner-Lambert's Procanbid

Executive Summary

Warner-Lambert's Procanbid: Procainamide extended-release 500 mg and 1,000 mg tablets for twice-daily treatment of life-threatening ventricular arrhythmia will be in pharmacies in March and available for patients by late April, following Jan. 31 approval. AWP will be $2.50-$4.50 per day depending on dose. NDA 20-545 for Procanbid was filed in December 1994...
UsernamePublicRestriction

Register

PS027593

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel